Onco-Innovations Limited
Onco-Innovations Limited
CSE Index:
Currency:
Onco-Innovations Limited is a Canadian biotech company dedicated to developing and commercializing treatments for various types of cancer. The company holds an exclusive license for the PNKP Inhibitor Technology and an exclusive sublicense for the Drug Delivery Technology. Together, these technologies have shown the potential to significantly enhance treatment outcomes, particularly for colorectal cancer.
Onco-Innovations Limited (ONCO)
SEDAR Information
Company Info
Address
1309-7th Street SW
Vancouver, BC V6C 2B5
CanadaPhone
(236) 521-0626Email
[email protected]Website
https://www.oncoinnovations.comListing date
Tuesday, November 26, 2024Transfer Agent
Endeavor Trust CorporationCapitalization
Issued & Outstanding:
43675000Reserved for Issuance:
7615000Company Officers
Thomas O'Shaughnessy, CEO
Nico Mah, CFO and Corporate Secretary
News Releases
Bulletins
26/11/2024
2024-1133 - New Listing - Onco-Innovations Limited (ONCO)
Le 26 novembre/November 2024
The common shares of Onco-Innovations Limited have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
